Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Brain scans reveal sex differences in Smokers' glutamate levels

NCT ID NCT05279053

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how smoking affects a brain chemical called glutamate in men versus women. Researchers scanned the brains of 58 smokers after not smoking overnight and after their first cigarette of the day. They also measured hormone levels in women to see if hormones influence brain chemistry. The goal was to better understand sex differences in smoking addiction, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

58 people

The number who actually took part.

Started

Apr 2021

Finished

Mar 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Target recruitment: 60 adult daily smokers (30 men and 30 women; 18-45 years old), who are otherwise in good health. Interested individuals will be invited to participate in the research project regardless of sex, race or ethnicity, although strong efforts will be made to recruit equal numbers of male and female participants. Individuals will not be excluded from study participation based on race/ethnicity.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Self-identified as only male or female 2. Age 18-45 years (children \<18 years will be excluded due to low prevalence of conventional cigarette smoking; female participants \>45 years of age will be excluded to avoid effects of perimenopause and menopause in women; male participants \>45 years of age will be excluded as well to ensure that male and female groups are matched on age 3. English fluency demonstrated by verbal skills sufficient to participate in a conversation, including the ability to ask and answer questions at a level that assures adequate understanding of the study (a comprehension quiz will be given) 4. Right handedness (evaluated using the Edinburgh Inventory) 5. Generally in good health without cardiovascular, hepatic, renal, or autoimmune diseases, diabetes, or cancer 6. Must have smoked for ≥1 year 7. Must endorse inhaling while smoking 8. Must smoke ≥10 cigarettes per day 9. Must have expired CO \>10 ppm and urinary cotinine ≥100 ng/ml at screening/intake 10. Fulfillment of DSM-5 criteria for Tobacco Use Disorder Exclusion Criteria: 1. Seeking treatment for nicotine dependence within 3 months of screening 2. Medical condition that may compromise safety (based on history, physical exam) 3. Neurological disorder that would compromise compliance and/or informed consent 4. Major psychiatric disorder (e.g., Major Depression, Schizophrenia, Bipolar Disorder) per DSM-5 MINI 5. Current drug use disorders other than Tobacco Use Disorder (as defined in DSM-5) 6. Recent use of cocaine, opiates, benzodiazepines, or amphetamines as shown by urine test at the screening or testing sessions 7. Smoke marijuana \>3X/week (self-report) or positive marijuana urine test on a scan day (positive at screening allowed) 8. Use of tobacco in forms other than cigarettes (e.g., snuff, chewing tobacco, e-cigarettes) \>10 days in the month before screening 9. Preference for menthol cigarettes, given sex differences in the effect of menthol on the rate of nicotine entry into the brain 10. Pregnancy or nursing 11. Presence in the body of metal that would compromise safety during MRI 12. Claustrophobia 13. Any other condition that would compromise safety

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cigarette smoking are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cigarette Smoking Coitus nicotine dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UCLA Semel Institute

    Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.